Search research articles
Contact Us
Filters
Showing results (21-30 of 27) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 27 results.
Biochemical Pharmacology
|
April 28, 2024
Developing insulin-like peptide 5-based antagonists for the G protein-coupled receptor, RXFP4
Hongkang Wu, Thomas N G Handley, Bradley L Hoare, et al.
Journal of Medicinal Chemistry
|
November 21, 2024
Engineering of Novel Analogues That Are More Receptor-Selective and Potent than the Native Hormone, Insulin-like Peptide 5 (INSL5)
Hongkang Wu, Herodion A Hartono, Thomas N G Handley, et al.
RSC Chemical Biology
|
June 8, 2026
Understanding insulin-like peptide 5 (INSL5) and relaxin family peptide receptor 4 (RXFP4): structure, signalling, and function
Hongkang Wu, Huahao Wang, Isabelle Riches, et al.
Journal of Medicinal Chemistry
|
November 19, 2021
Engineering of a Biologically Active Insulin Dimer
Mengjie Liu, Barbara F White, Praveen Praveen, et al.
BMC Biology
|
February 26, 2025
Receptor deorphanization in starfish reveals the evolution of relaxin signaling as a regulator of reproduction
Yuling Feng, Nayeli Escudero Castelán, Mohammed Akhter Hossain, et al.
ACS Medicinal Chemistry Letters
|
November 19, 2025
Design and Synthesis of a Structurally Stabilized B‑Chain Antagonist Targeting Relaxin Family Peptide Receptor 3 (RXFP3)
Hongkang Wu, Praveen Praveen, Isabelle Riches, et al.
NPJ Digital Medicine
|
July 2, 2025
Generative artificial intelligence for fundus fluorescein angiography interpretation and human expert evaluation
An Shao, Xiaocong Liu, Wenyue Shen, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 27) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 27 results.
Biochemical Pharmacology
|
April 28, 2024
Developing insulin-like peptide 5-based antagonists for the G protein-coupled receptor, RXFP4
Hongkang Wu, Thomas N G Handley, Bradley L Hoare, et al.
Journal of Medicinal Chemistry
|
November 21, 2024
Engineering of Novel Analogues That Are More Receptor-Selective and Potent than the Native Hormone, Insulin-like Peptide 5 (INSL5)
Hongkang Wu, Herodion A Hartono, Thomas N G Handley, et al.
RSC Chemical Biology
|
June 8, 2026
Understanding insulin-like peptide 5 (INSL5) and relaxin family peptide receptor 4 (RXFP4): structure, signalling, and function
Hongkang Wu, Huahao Wang, Isabelle Riches, et al.
Journal of Medicinal Chemistry
|
November 19, 2021
Engineering of a Biologically Active Insulin Dimer
Mengjie Liu, Barbara F White, Praveen Praveen, et al.
BMC Biology
|
February 26, 2025
Receptor deorphanization in starfish reveals the evolution of relaxin signaling as a regulator of reproduction
Yuling Feng, Nayeli Escudero Castelán, Mohammed Akhter Hossain, et al.
ACS Medicinal Chemistry Letters
|
November 19, 2025
Design and Synthesis of a Structurally Stabilized B‑Chain Antagonist Targeting Relaxin Family Peptide Receptor 3 (RXFP3)
Hongkang Wu, Praveen Praveen, Isabelle Riches, et al.
NPJ Digital Medicine
|
July 2, 2025
Generative artificial intelligence for fundus fluorescein angiography interpretation and human expert evaluation
An Shao, Xiaocong Liu, Wenyue Shen, et al.
Page
of 3